NCT06062537Active, not recruiting
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients: a Collaborative Janssen - IFM Study IFM 2023-01: TEC-CARE
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
200 adult patients with multiple myeloma receiving teclistamb will be included. Effectiveness, safety, and condition of use of teclistamab in early access program (post-MA) will be assessed. Primary objective is the evaluation of overall response rate (ORR) of teclistamab according to IMWG criteria. This is a multicenter, prospective, observational study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 22 Sept 2023
- Start date
- 19 Sept 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Intergroupe Francophone du Myelome
- Diseases
- Multiple myeloma
- NCT number
- NCT06062537
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 19 Sept 2023 to the primary completion date, Dec 2026
- 31 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who received teclistamab as part of an interventional clinical trial
Other
- Patients alive at the start of the study who did not receive study information or who objected to the collection of data
- Patients who are initiating teclistamab as part of a current interventional clinical trial
Who the study is looking for
- Adult patient (≥18 years) with multiple myeloma who will receive at least one dose of teclistamab (first dose of the step-up dose)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (31)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu Amiens Picardie Coordinator of this site? Confirm its status | Amiens | France | Unknown status |
| CH d'ANNECY Coordinator of this site? Confirm its status | Annecy | France | Unknown status |
| Centre hospitalier d'Argenteuil Coordinator of this site? Confirm its status | Argenteuil | France | Unknown status |
| Hopital de la cote Basque Coordinator of this site? Confirm its status | Bayonne | France | Unknown status |
| CHU de Besançon Coordinator of this site? Confirm its status | Besançon | France | Unknown status |
| CHU Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
| Centre hospitalier de Brive-la-Gaillarde Coordinator of this site? Confirm its status | Brive-la-Gaillarde | France | Unknown status |
| CHU Caen Coordinator of this site? Confirm its status | Caen | France | Unknown status |
| Centre Hospitalier Métropole de Savoie Coordinator of this site? Confirm its status | Chambéry | France | Unknown status |
| CHU Clermont-Ferrand Site Estaing Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| CHU Henri Mondor Coordinator of this site? Confirm its status | Créteil | France | Unknown status |
| CHU Dijon Coordinator of this site? Confirm its status | Dijon | France | Unknown status |
| CH Dunkerque Coordinator of this site? Confirm its status | Dunkirk | France | Unknown status |
| CHU de Lille Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| Groupe Hospitalier Bretagne Sud Coordinator of this site? Confirm its status | Lorient | France | Unknown status |
| Institut Paoli-Calmette Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
| CH de METZ Coordinator of this site? Confirm its status | Metz | France | Unknown status |
| CHU Saint-Eloi - CHU de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| CHU de Nantes Coordinator of this site? Confirm its status | Nantes | France | Unknown status |
| CHU de Nice Coordinator of this site? Confirm its status | Nice | France | Unknown status |
| Hopital Saint Louis Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Hôpital Necker Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Ch Perpignan Coordinator of this site? Confirm its status | Perpignan | France | Unknown status |
| Hôpital NOVO Coordinator of this site? Confirm its status | Pontoise | France | Unknown status |
| CHU de Rennes Coordinator of this site? Confirm its status | Rennes | France | Unknown status |
| Centre Henri Becquerel Coordinator of this site? Confirm its status | Rouen | France | Unknown status |
| Institut de Cancérologie Lucien Neuwirth, CHU Saint-Etienne Coordinator of this site? Confirm its status | Saint-Priest-en-Jarez | France | Unknown status |
| Hôpital de Hautepierre Coordinator of this site? Confirm its status | Strasbourg | France | Unknown status |
| CHU Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
| CHU de Tours Coordinator of this site? Confirm its status | Tours | France | Unknown status |
| CH Bretagne Atlantique Coordinator of this site? Confirm its status | Vannes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.